Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07292272 · ClinicalTrials.gov registry record · NA
Halt Aging in Survivors of Blood Cancers
A NA study, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT07292272: Recruiting NA study, sponsored by University of Nebraska.
NCT07292272 is a NA study that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07292272, a NA study, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.
Primary Outcome
Participants achieving at least 120 minutes per week of moderate-intensity aerobic exercise, measured using Polar heart rate monitor data and exercise diaries.
Interventions
- BEHAVIORAL Behavioral Coaching Intervention
- BEHAVIORAL Virtual Exercise Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2033-03-25 |
| Phase | NA |
What NCT07292272 shows while recruiting
NCT07292272 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Coaching Intervention is the first listed.
NCT07292272 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07292272 about?
NCT07292272 is a clinical study titled "Halt Aging in Survivors of Blood Cancers". Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the...
What is the current status of trial NCT07292272?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-04-09. Estimated completion is 2033-03-25.
What interventions are being tested in trial NCT07292272?
The interventions under investigation include: Behavioral Coaching Intervention (BEHAVIORAL), Virtual Exercise Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT07292272?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07292272's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI